Search
forResearch 10 of 1000+
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- 566 Staphylococcus epidermidis for the topical treatment of epidermal growth factor receptor (EGFR) inhibitor-induced dermal toxicity
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Network pharmacology-based preventive effect of XZF on cutaneous toxicities induced by EGFR inhibitor
- 861 EGFR/MEK inhibitor therapy induces partial hair follicle immune privilege collapse in vivo and ex vivo
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Depletion of <i>Gsdma1/2/3</i> alleviates PMA-induced epidermal hyperplasia by inhibiting the EGFR–Stat3/Akt pathway
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →